Back

RIVER: Rivaroxaban for Valvular Heart Disease and Atrial Fibrillation

28 August 2023 (16:45 - 17:00)
Organised by: Logo
Congress Presentation Part of: Late-breaking science on valve disease and hypertrophic cardiomyopathy Pharmacotherapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Pedro Gabriel Barros E Silva

Brazilian Clinical Research Institute (BCRI), Sao Paulo (Brazil)

3 More presentations in this session

Presentation thumbnail
NOTION - The Nordic Aortic Valve Intervention Trial
Doctor T. Jorgensen (Copenhagen, DK)
Slides Video
Presentation thumbnail
EXPLORER-CN - Efficacy and safety of mavacamten in Chinese adults with symptomatic obstructive hypertrophic cardiomyopathy
Doctor Z. Tian (Beijing, CN)
Slides
Presentation thumbnail
VALOR-HCM 56 Week Long-term Extension Study in oHCM
Doctor M. Desai (Cleveland, US)
Slides

Access the full session

Session thumbnail
Late-breaking science on valve disease and hypertrophic cardiomyopathy
Video

The Event

Event poster

ESC Congress 2023

28 August 2023 16:45 CET
You may be interested in
thumbnail
Congress Session
Late-breaking science on valve disease and hypertrophic cardiomyopathy
thumbnail
Congress Session
HOT LINE 5
thumbnail
Congress Presentation
RHEIA - Transcatheter versus surgical aortic valve replacement in women with severe aortic stenosis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources